Scalable and Impurity-Free Process for Dasatinib: Src and BCR-Abl Inhibitor

摘要

An efficient, telescopic, impurity-free and scalable process for Ber-Abl and Src family tyrosine kinase inhibitor for synthesis of Dasatinib with high yield and purity is described.